All the news Showing 10 of 12 articles from: CoronavirusGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources International registries provide more information about COVID-19 and liver disease Liz Highleyman / 17 September 2020 People with advanced liver cirrhosis are more likely to develop severe COVID-19 complications and to die from it, but those who have received liver transplants do not appear to be at greater ... EASL updates guidance on COVID-19 in liver disease patients Keith Alcorn / 11 August 2020 The European Association for the Study of the Liver (EASL) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) have updated their guidance on chronic liver disease and COVID-19, issued in ... COVID-19 slows hepatitis elimination Keith Alcorn / 04 August 2020 Hepatitis elimination efforts are being severely affected by the COVID-19 pandemic in many settings, results of a 32-country survey by the World Hepatitis Alliance show. The survey of civil society hepatitis organisations and frontline ... How often does COVID-19 cause liver disorders? Keith Alcorn / 21 July 2020 Increases in liver enzymes are common in people with COVID-19 and occur more frequently in people with severe COVID-19, a meta-analysis of studies published in Hepatology International shows. Most liver enzyme elevations were ... Hepatitis C drugs may offer an inexpensive treatment option for COVID-19 Liz Highleyman / 20 July 2020 Sofosbuvir and daclatasvir, two antiviral drugs used to treat hepatitis C, were associated with faster recovery, shorter hospitalisation and improve survival among people with moderate or severe COVID-19, researchers reported this month at the ... Cirrhosis raises the risk of liver injury in COVID-19 patients Keith Alcorn / 13 July 2020 People with cirrhosis, especially those with diabetes or obesity, are more likely to suffer significant liver injury after contracting SARS-CoV-2 than others with chronic liver disease, Asian liver specialists report in a ... Non-alcoholic fatty liver disease does not raise the risk of COVID-19, gene study shows Keith Alcorn / 26 May 2020 People with a genetic profile that strongly predicts non-alcoholic or metabolic-associated fatty liver disease were not at higher risk of being hospitalised with COVID-19 in the United Kingdom, an analysis of the ... COVID-19 in chronic liver disease: advanced cirrhosis greatly raises risk of death Keith Alcorn / 22 May 2020 People with chronic liver disease admitted to hospital with COVID-19 are dying at a much higher rate than the rest of the population, figures collated by liver specialists in Europe, Asia and ... Liver transplants and COVID-19 Keith Alcorn / 28 April 2020 Liver specialists in New York report a high frequency of severe COVID-19 cases in organ transplant recipients who became infected with SARS-CoV-2, while Italian specialists report that 15 of 17 patients who underwent ... Fatty liver disease may increase risk of severe COVID-19 disease Keith Alcorn / 27 April 2020 A preliminary analysis of people admitted to hospital in China with COVID-19 symptoms shows that people with non-alcoholic fatty liver disease (NAFLD) were six times more likely to progress to severe COVID-19 ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds